NEW YORK (GenomeWeb News) – Saladax Biomedical on Thursday said that its Saladax Biomedical Laboratories division has received licenses from three states allowing it to provide its MyCare tests to clinicians in those states.

The licenses were granted by regulators in California, Rhode Island, and Maryland.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.